Compare · ADVB vs ELV
ADVB vs ELV
Side-by-side comparison of Advanced Biomed Inc. (ADVB) and Elevance Health Inc. (ELV): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ADVB and ELV operate in Medical Specialities (Health Care), so they compete in similar markets.
- ELV is the larger of the two at $88.91B, about 15101.3x ADVB ($5.9M).
- Over the past year, ADVB is down 77.6% and ELV is up 6.4% - ELV leads by 84.0 points.
- ELV has been more active in the news (13 items in the past 4 weeks vs 2 for ADVB).
- ELV has more recent analyst coverage (23 ratings vs 0 for ADVB).
PerformanceADVB-77.56%ELV+6.44%
2025-06-05+0.00%2026-06-04
- Company
- Advanced Biomed Inc.
- Elevance Health Inc.
- Price
- $4.30-7.73%
- $409.45+4.65%
- Market cap
- $5.9M
- $88.91B
- 1M return
- -40.85%
- +10.96%
- 1Y return
- -77.56%
- +6.44%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NASDAQ
- NYSE
- IPO
- 2025
- News (4w)
- 2
- 13
- Recent ratings
- 0
- 23
ELV
Elevance Health Inc.
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
Latest ADVB
- SEC Form DEF 14A filed by Advanced Biomed Inc.
- SEC Form 10-Q filed by Advanced Biomed Inc.
- Advanced Biomed Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity Securities, Leadership Update, Financial Statements and Exhibits
- Advanced Biomed Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
- Advanced Biomed Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
- Advanced Biomed Inc. filed SEC Form 8-K: Leadership Update
- Advanced Biomed Inc. filed SEC Form 8-K: Other Events
- Advanced Biomed Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits
- Advanced Biomed Inc. Announces 1 for 20 Share Consolidation
- SEC Form 10-Q filed by Advanced Biomed Inc.
Latest ELV
- Elevance Health Expands Access to Digital Tools, Helping Bridge the Healthcare Digital Divide
- CAO & Controller Penczek Ronald W exercised 1,531 shares at a strike of $294.30 and sold $617,192 worth of shares (1,531 units at $403.13) (SEC Form 4)
- Elevance Health upgraded by Deutsche Bank with a new price target
- Director Schulman Amy W was granted 563 shares, increasing direct ownership by 258% to 781 units (SEC Form 4)
- Director Schneider Ryan M. was granted 563 shares, increasing direct ownership by 9% to 7,163 units (SEC Form 4)
- Director Peru Ramiro G was granted 563 shares, increasing direct ownership by 6% to 9,908 units (SEC Form 4)
- Director Neri Antonio F was granted 563 shares, increasing direct ownership by 11% to 5,488 units (SEC Form 4)
- Director Jallal Bahija was granted 563 shares, increasing direct ownership by 12% to 5,351 units (SEC Form 4)
- Director Hay Lewis Iii was granted 563 shares, increasing direct ownership by 5% to 12,070 units (SEC Form 4)
- Director Dixon Robert L Jr was granted 563 shares, increasing direct ownership by 5% to 10,885 units (SEC Form 4)